New drug combo aims to wipe out breast cancer before surgery

NCT ID NCT07102381

Recruiting now Disease control Sponsor: Jazz Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding an experimental drug called zanidatamab to standard chemotherapy helps eliminate HER2-positive breast cancer before surgery. Researchers will enroll 125 people with early-stage breast cancer to see if this combination leads to better outcomes. The main goal is to measure how many participants have no detectable cancer left in their tissue after treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Accellacare of McFarland
RECRUITING

Ames, Iowa, 50010, United States
Astera Cancer Care (Formerly Regional Cancer Care Associates)
RECRUITING

East Brunswick, New Jersey, 08816, United States
Cancer Partners of Nebraska
RECRUITING

Lincoln, Nebraska, 68516, United States
Hematology Oncology Associates of Central New York
RECRUITING

Camillus, New York, 13031, United States
LSU Health Sciences Center
RECRUITING

Shreveport, Louisiana, 71103, United States
Maryland Oncology Hematology
RECRUITING

Laurel, Maryland, 20707, United States
Medical Oncology Hematology Associates
RECRUITING

Newark, New Jersey, 19713, United States
Nebraska Cancer Specialists
RECRUITING

Omaha, Nebraska, 68124, United States
New England Cancer Specialists
RECRUITING

Scarborough, Maine, 04074, United States
Northwest Cancer Specialists
RECRUITING

Vancouver, Washington, 98648, United States
Northwest Medical Specialties
RECRUITING

Puyallup, Washington, 98373, United States
Oncology Institute
RECRUITING

Long Beach, California, 90805, United States
Rocky Mountain Cancer Centers
RECRUITING

Denver, Colorado, 80218, United States
Sarah Cannon Research Institute (Nashville)
RECRUITING

Nashville, Tennessee, 37203, United States
Shenandoah Oncology
RECRUITING

Winchester, Virginia, 22601, United States
Texas Oncology DFW
RECRUITING

Dallas, Texas, 75246, United States
Texas Oncology Gulf Coast
RECRUITING

Houston, Texas, 77024, United States
The Oncology Institute
RECRUITING

Lakeland, Florida, 33812, United States
The University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
Virginia Cancer Specialists
RECRUITING

Fairfax, Virginia, 22031, United States
Virginia Oncology Associates
RECRUITING

Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.

BREAST CANCER HER2-POSITIVE BREAST CANCER